BG63046B1 - Пиролидинилметилиндолова сол - Google Patents
Пиролидинилметилиндолова сол Download PDFInfo
- Publication number
- BG63046B1 BG63046B1 BG102053A BG10205397A BG63046B1 BG 63046 B1 BG63046 B1 BG 63046B1 BG 102053 A BG102053 A BG 102053A BG 10205397 A BG10205397 A BG 10205397A BG 63046 B1 BG63046 B1 BG 63046B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- salt
- fumarate salt
- compound
- fumarate
- free base
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9510223.2A GB9510223D0 (en) | 1995-05-20 | 1995-05-20 | Therapeutic agent |
| PCT/EP1996/001560 WO1996036632A1 (en) | 1995-05-20 | 1996-04-10 | Pyrrolidinyl methyl indole salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG102053A BG102053A (en) | 1998-06-30 |
| BG63046B1 true BG63046B1 (bg) | 2001-02-28 |
Family
ID=10774766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG102053A BG63046B1 (bg) | 1995-05-20 | 1997-11-18 | Пиролидинилметилиндолова сол |
Country Status (42)
| Country | Link |
|---|---|
| US (1) | US5994387A (is) |
| EP (1) | EP0827503B1 (is) |
| JP (1) | JP3233940B2 (is) |
| KR (1) | KR100295255B1 (is) |
| CN (1) | CN1063175C (is) |
| AP (1) | AP738A (is) |
| AR (1) | AR003949A1 (is) |
| AT (1) | ATE194986T1 (is) |
| AU (1) | AU701154B2 (is) |
| BG (1) | BG63046B1 (is) |
| BR (1) | BR9610858A (is) |
| CA (1) | CA2219631C (is) |
| CO (1) | CO5040221A1 (is) |
| CZ (1) | CZ287939B6 (is) |
| DE (1) | DE69609504T2 (is) |
| DK (1) | DK0827503T3 (is) |
| DZ (1) | DZ2034A1 (is) |
| ES (1) | ES2148753T3 (is) |
| GB (1) | GB9510223D0 (is) |
| GR (1) | GR3034290T3 (is) |
| HK (1) | HK1017884A1 (is) |
| HR (1) | HRP960223B1 (is) |
| HU (1) | HU217657B (is) |
| IL (1) | IL118239A (is) |
| IS (1) | IS1908B (is) |
| LV (1) | LV11992B (is) |
| MA (1) | MA23876A1 (is) |
| MX (1) | MX9708966A (is) |
| MY (1) | MY132066A (is) |
| NO (1) | NO312068B1 (is) |
| NZ (1) | NZ306448A (is) |
| OA (1) | OA10747A (is) |
| PL (1) | PL183142B1 (is) |
| PT (1) | PT827503E (is) |
| RU (1) | RU2161618C2 (is) |
| SK (1) | SK281782B6 (is) |
| TN (1) | TNSN96074A1 (is) |
| TR (1) | TR199701397T1 (is) |
| UA (1) | UA44320C2 (is) |
| WO (1) | WO1996036632A1 (is) |
| YU (1) | YU29496A (is) |
| ZA (1) | ZA963938B (is) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| US20100266638A1 (en) * | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
| EP2875020B1 (en) * | 2012-07-19 | 2017-09-06 | Boehringer Ingelheim International GmbH | Process for the preparation of a fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3906406C1 (is) * | 1989-03-01 | 1990-10-25 | Goedecke Ag, 1000 Berlin, De | |
| HUT64326A (en) * | 1990-10-15 | 1993-12-28 | Pfizer | Process for production indole derivatives and pharmaceutical preparations containing these compounds |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| AP486A (en) * | 1993-04-27 | 1996-04-16 | Pfizer | Indole derivatives. |
-
1995
- 1995-05-20 GB GBGB9510223.2A patent/GB9510223D0/en active Pending
-
1996
- 1996-04-10 WO PCT/EP1996/001560 patent/WO1996036632A1/en active IP Right Grant
- 1996-04-10 EP EP96912013A patent/EP0827503B1/en not_active Expired - Lifetime
- 1996-04-10 HU HU9801761A patent/HU217657B/hu not_active IP Right Cessation
- 1996-04-10 NZ NZ306448A patent/NZ306448A/xx unknown
- 1996-04-10 CN CN96194043A patent/CN1063175C/zh not_active Expired - Fee Related
- 1996-04-10 JP JP53448896A patent/JP3233940B2/ja not_active Expired - Fee Related
- 1996-04-10 BR BR9610858A patent/BR9610858A/pt not_active Application Discontinuation
- 1996-04-10 KR KR1019970708280A patent/KR100295255B1/ko not_active IP Right Cessation
- 1996-04-10 SK SK1541-97A patent/SK281782B6/sk unknown
- 1996-04-10 PL PL96323143A patent/PL183142B1/pl unknown
- 1996-04-10 US US08/952,792 patent/US5994387A/en not_active Expired - Fee Related
- 1996-04-10 MX MX9708966A patent/MX9708966A/es not_active IP Right Cessation
- 1996-04-10 AT AT96912013T patent/ATE194986T1/de not_active IP Right Cessation
- 1996-04-10 RU RU97120998/04A patent/RU2161618C2/ru not_active IP Right Cessation
- 1996-04-10 AU AU55005/96A patent/AU701154B2/en not_active Ceased
- 1996-04-10 DK DK96912013T patent/DK0827503T3/da active
- 1996-04-10 CA CA002219631A patent/CA2219631C/en not_active Expired - Fee Related
- 1996-04-10 UA UA97126158A patent/UA44320C2/uk unknown
- 1996-04-10 PT PT96912013T patent/PT827503E/pt unknown
- 1996-04-10 DE DE69609504T patent/DE69609504T2/de not_active Expired - Fee Related
- 1996-04-10 CZ CZ19973648A patent/CZ287939B6/cs not_active IP Right Cessation
- 1996-04-10 TR TR97/01397T patent/TR199701397T1/xx unknown
- 1996-04-10 ES ES96912013T patent/ES2148753T3/es not_active Expired - Lifetime
- 1996-04-11 AP APAP/P/1996/000801A patent/AP738A/en active
- 1996-05-10 AR ARP960102519A patent/AR003949A1/es unknown
- 1996-05-13 IL IL11823996A patent/IL118239A/xx not_active IP Right Cessation
- 1996-05-16 HR HR960223A patent/HRP960223B1/xx not_active IP Right Cessation
- 1996-05-16 YU YU29496A patent/YU29496A/sh unknown
- 1996-05-17 CO CO96025158A patent/CO5040221A1/es unknown
- 1996-05-17 ZA ZA9603938A patent/ZA963938B/xx unknown
- 1996-05-17 TN TNTNSN96074A patent/TNSN96074A1/fr unknown
- 1996-05-17 MY MYPI96001888A patent/MY132066A/en unknown
- 1996-05-17 MA MA24243A patent/MA23876A1/fr unknown
- 1996-05-18 DZ DZ960077A patent/DZ2034A1/fr active
-
1997
- 1997-10-30 IS IS4605A patent/IS1908B/is unknown
- 1997-11-13 NO NO19975210A patent/NO312068B1/no not_active IP Right Cessation
- 1997-11-18 BG BG102053A patent/BG63046B1/bg unknown
- 1997-11-20 OA OA70132A patent/OA10747A/en unknown
- 1997-12-11 LV LVP-97-256A patent/LV11992B/en unknown
-
1998
- 1998-10-20 HK HK98111337A patent/HK1017884A1/xx not_active IP Right Cessation
-
2000
- 2000-08-30 GR GR20000401977T patent/GR3034290T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533396A (ja) | Ｇｓｋ１２７８８６３の結晶形及びその製造方法並びに医薬用途 | |
| EA011283B1 (ru) | Гидрохлорид дигидрат (s)-(-)-1-(4-фторизохинолин-5-ил)сульфонил-2-метил-1,4-гомопиперазина | |
| US20200283371A1 (en) | Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or of derivative thereof and method for preparing same | |
| FR2883285A1 (fr) | Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique | |
| JP2022529915A (ja) | 新規な製剤 | |
| JP2023504912A (ja) | ７ｈ－ベンゾ［７］アヌレン－２－カルボン酸誘導体の結晶形態 | |
| EP1641787B1 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| US5747521A (en) | N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same | |
| BG63046B1 (bg) | Пиролидинилметилиндолова сол | |
| EP2874628A2 (en) | Salts and hydrates of antipsychotics | |
| TWI285204B (en) | Polymorphs of a crystalline azabicyclo[2,2.2]octan-3-amine citrate and their pharmaceutical compositions | |
| ES2397413T3 (es) | Procedimiento para la preparación de un comprimido que contiene clorhidrato de donepezilo en forma amorfa | |
| WO2020072860A1 (en) | Niraparib solid state form | |
| JP2019089822A (ja) | トピロキソスタットの新規結晶形及びその製造方法 | |
| US20230382897A1 (en) | Crystalline form of lifitegrast, and pharmaceutical composition comprising the same | |
| JP7425482B2 (ja) | イソキノリンスルホンアミドの新規な形態 | |
| WO2005023803A1 (en) | Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione | |
| KR20210046028A (ko) | 트레프로스티닐의 에르부민 염 | |
| WO2005023790A1 (en) | (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid sodium salt | |
| WO2005023789A1 (en) | Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid |